Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2003 Nov;14(5):350-5; discussion 355.
doi: 10.1007/s00192-003-1084-x. Epub 2003 Sep 23.

Sacrospinous hysteropexy compared to vaginal hysterectomy as primary surgical treatment for a descensus uteri: effects on urinary symptoms

Affiliations
Comparative Study

Sacrospinous hysteropexy compared to vaginal hysterectomy as primary surgical treatment for a descensus uteri: effects on urinary symptoms

H J van Brummen et al. Int Urogynecol J Pelvic Floor Dysfunct. 2003 Nov.

Abstract

One hundred and three women underwent sacrospinous hysteropexy (n=54) or vaginal hysterectomy with a vaginal vault suspension (n=49) for the management of descensus uteri. They were sent a postal questionnaire. Logistic regression analysis was used to obtain crude and adjusted odds ratios. Seventy-four (72%) women responded. The adjusted odds ratios for urge incontinence is 3.4 (1.0-12.3) and for overactive bladder 2.9 (0.5-16.9) greater after vaginal hysterectomy. The women recovered significantly more quickly after sacrospinous hysteropexy. There were no differences in anatomical outcome or recurrence rate. When performed to correct a descensus uteri of grade 2 or more we found that vaginal hysterectomy is associated with a three times higher risk for urge incontinence and overactive bladder symptoms. In addition, the women who underwent sacrospinous hysteropexy also reported a quicker recovery from surgery. Sacrospinous hysteropexy, therefore, appears to be promising for the correction of descensus uteri.

PubMed Disclaimer

References

    1. Am J Obstet Gynecol. 1982 Apr 1;142(7):901-4 - PubMed
    1. Lancet. 2000 Aug 12;356(9229):535-9 - PubMed
    1. Gynecol Obstet Invest. 1999;47(1):65-8 - PubMed
    1. Neurourol Urodyn. 2003;22(2):97-104 - PubMed
    1. Clin Obstet Gynecol. 1972 Dec;15(4):1048-54 - PubMed

Publication types

LinkOut - more resources